So, in most dogs with multiple
myeloma chemotherapy is the treatment of choice.
KLF9 - Novel Transcriptional Regulator of Multiple
Myeloma Chemotherapy Resistance Multiple myeloma (MM) is a plasma cell disorder that accounts for approximately 10 % of all hematologic malignancies.
Not exact matches
With multiple
myeloma, most patients live four to seven years from their date of diagnosis, and most become resistant to
chemotherapy drugs over time.
A randomized phase III trial finding that a new monoclonal antibody, elotuzumab, added to standard therapy, extended the duration of remission for patients with relapsed multiple
myeloma by about five months Findings from two phase III studies showing that children with Wilms tumor who have a specific chromosomal abnormality do better with a more intensive, augmented
chemotherapy regimen
A new therapeutic approach tested by a team from Maisonneuve - Rosemont Hospital (CIUSSS - EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple
myeloma, a cancer of the bone marrow currently considered incurable with conventional
chemotherapy and for which the average life expectancy is about 6 or 7 years.
«Multiple
myeloma patient study shows promise for natural killer cells: Phase I study included combination with high - dose
chemotherapy and stem cell transplantation.»
The team designed a different approach to study the therapy in
myeloma, adding in an infusion of the patient's own stem cells along with their lymphodepleting
chemotherapy (melphalan), followed by CTL019 infusion about two weeks later.
The investigational treatment was combined with
chemotherapy and an autologous stem cell transplant — a new strategy designed to target and kill the cells that give rise to
myeloma cells.
Stem Cells Make Bone Marrow Cancer Resistant to Treatment Scientists at the Johns Hopkins Kimmel Cancer Center provided evidence that cancer stem cells for multiple
myeloma share many properties with normal stem cells and have multiple ways of resisting
chemotherapy and other treatments.
Tim was treated with lenalidomide (Revlimid) and dexamethasone, a
chemotherapy regimen commonly used to treat multiple
myeloma.
I continued under the care of an oncologist and eventually the
myeloma returned and I returned to
chemotherapy treatment.
two years back we discontinued it as he developed multiple
myeloma because of the side effect of anti depressants... we did homeopathy for 6 months and then
chemotherapy for one and half years.